Microbial Identification Market Report 2026

Microbial Identification Market Overview

• Microbial Identification market size has reached to $6.42 billion in 2025 • Expected to grow to $12.09 billion in 2030 at a compound annual growth rate (CAGR) of 13% • Growth Driver: Burden Of Infectious Diseases Exploring Health And Socioeconomic Impacts • Market Trend: Automated Systems Transform Microbial Identification • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Microbial Identification Market?

Microbial identification refers to the process of determining and classifying microorganisms (such as bacteria, fungi, viruses, and protozoa) based on their phenotypic and genotypic characteristics. The integration of these methods allows for accurate, rapid, and comprehensive identification of microorganisms, which is crucial for diagnosis, treatment, and monitoring of infections. The main product types and services of microbial identification are instruments, consumables, and services. Microbial identification instruments are tools and devices used to detect, classify, and identify microorganisms such as bacteria, viruses, fungi, and parasites. The various methods include phenotypic methods, proteotypic methods, and genotypic methods that are used in various applications such as diagnostic applications, environmental applications, food and beverages testing, pharmaceutical applications, and also by various end users such as the pharmaceutical and biotechnology industry, food and beverage industry, water and environment industry, independent research laboratories, diagnostic laboratories, hospitals, others.

What Is The Microbial Identification Market Growth Forecast?

The microbial identification market size is expected to see rapid growth in the next few years. It will grow to $12.09 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to advancements in sequencing technologies, rising demand for rapid diagnostic methods, increasing automation in laboratory workflows, integration of digital platforms in microbial testing, expanding applications in pharmaceutical quality control. Major trends in the forecast period include genomic sequencing integration in microbial identification, cloud-based microbial data management, AI-assisted microorganism classification, automated identification platforms in industrial testing, iot-enabled monitoring in microbial detection.

What Is The Driver Of The Microbial Identification Market?

The rising prevalence of infectious diseases is expected to propel the growth of the microbial identification market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions. Infectious diseases occur due to climate change, environmental disruption, antimicrobial resistance, weakened immune systems, and ecological disturbances. Microbial identification is essential for accurate diagnosis, targeted treatment, disease surveillance, outbreak control, and antimicrobial stewardship in managing infectious diseases. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, reflecting an increase of 1,295 cases. Therefore, the rising prevalence of infectious diseases drives the microbial identification industry.

Key Players In The Global Microbial Identification Market

Major companies operating in the microbial identification market are Merck & Co Inc, ThermoFisher Scientific Inc, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Avantor Inc, Eurofins Scientific Corporation, Beckman Coulter Inc, VWR International LLC, Charles River Laboratories International Inc, PerkinElmer Inc, Wickham Micro Limited, Bruker Corporation, bioMérieux SA, Biolog Inc, Liofilchem Srl, Shimadzu Corporation, Scenker Biological Technology Co Ltd, Agilent Technologies Inc, Bio Rad Laboratories Inc, QIAGEN NV, Roche Diagnostics, Illumina Inc, Oxford Nanopore Technologies

Global Microbial Identification Market Trends and Insights

Major companies operating in the microbial identification market are focusing on developing advanced solutions, such as automated sample preparation platforms, to improve the speed and accuracy of microbial detection. Sample preparation platforms are technological systems that process and prepare biological or clinical samples for analysis, enhancing efficiency and diagnostic precision. For instance, in September 2024, Accelerate Diagnostics Inc., a US-based in vitro diagnostics company, received FDA clearance for the Accelerate Arc system, an advanced automated solution designed to rapidly identify microbes directly from positive blood culture samples. By automating the sample preparation process through integration with the Bruker MALDI Biotyper CA System, the solution significantly reduces the wait time for results, enabling clinicians to initiate targeted antibiotic therapy sooner, improve patient outcomes, and reduce the risk of antimicrobial resistance. FDA-cleared, the Accelerate Arc system is engineered to enhance operational efficiency in clinical laboratories.

What Are Latest Mergers And Acquisitions In The Microbial Identification Market?

In January 2023, Biolog Inc., a US-based cellular analysis tool, acquired MIDI Inc. for an undisclosed amount. With this acquisition, Biolog Inc. enhances its microbial identification and phenotypic profiling capabilities, broadening its offerings to provide comprehensive microbial analysis solutions. MIDI Inc. is a US-based microbial identification company that specializes in microbial identification and analysis.

What Defines the Microbial Identification Market?

The microbial identification market consists of revenues earned by entities by providing services such as custom and specialized testing, clinical diagnostics, and microbial source tracking. Only goods and services traded between entities or sold to end consumers are included. The microbial identification market also consists of sales of microarray systems, genomic instruments, and culture testing instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Microbial Identification Market Report 2026?

The microbial identification market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the microbial identification industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.